These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28572167)

  • 1. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
    Valero JG; Matas-Céspedes A; Arenas F; Rodriguez V; Carreras J; Serrat N; Guerrero-Hernández M; Yahiaoui A; Balagué O; Martin S; Capdevila C; Hernández L; Magnano L; Rivas-Delgado A; Tannheimer S; Cid MC; Campo E; López-Guillermo A; Colomer D; Pérez-Galán P
    Leukemia; 2021 Sep; 35(9):2635-2649. PubMed ID: 33731849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLX3397 inhibits the accumulation of intra-tumoral macrophages and improves bromodomain and extra-terminal inhibitor efficacy in melanoma.
    Erkes DA; Rosenbaum SR; Field CO; Chervoneva I; Villanueva J; Aplin AE
    Pigment Cell Melanoma Res; 2020 Mar; 33(2):372-377. PubMed ID: 31696640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
    Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.
    Guan W; Hu J; Yang L; Tan P; Tang Z; West BL; Bollag G; Xu H; Wu L
    Endocr Relat Cancer; 2019 Jan; 26(1):131-140. PubMed ID: 30400004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
    Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
    Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.
    Shimizu D; Yuge R; Kitadai Y; Ariyoshi M; Miyamoto R; Hiyama Y; Takigawa H; Urabe Y; Oka S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
    Mok S; Tsoi J; Koya RC; Hu-Lieskovan S; West BL; Bollag G; Graeber TG; Ribas A
    BMC Cancer; 2015 May; 15():356. PubMed ID: 25939769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony-Stimulating Factor 1 Receptor Antagonists Sensitize Human Immunodeficiency Virus Type 1-Infected Macrophages to TRAIL-Mediated Killing.
    Cunyat F; Rainho JN; West B; Swainson L; McCune JM; Stevenson M
    J Virol; 2016 Jul; 90(14):6255-6262. PubMed ID: 27122585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.
    Shi G; Yang Q; Zhang Y; Jiang Q; Lin Y; Yang S; Wang H; Cheng L; Zhang X; Li Y; Wang Q; Liu Y; Wang Q; Zhang H; Su X; Dai L; Liu L; Zhang S; Li J; Li Z; Yang Y; Yu D; Wei Y; Deng H
    Mol Ther; 2019 Jan; 27(1):244-260. PubMed ID: 30527756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
    Pang L; Pei Y; Uzunalli G; Hyun H; Lyle LT; Yeo Y
    Pharm Res; 2019 Mar; 36(4):65. PubMed ID: 30859335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of colony-stimulating factor 1 receptor inhibitor pexidartinib on the senescence of mouse bone marrow-derived macrophages stimulated by lipopolysaccharide].
    Xiao TJ; Zhang J; Kang JB; Li L; Zhan JF; Wei Y; Tian A
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2023 Jun; 58(6):575-583. PubMed ID: 37272003
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.
    Dammeijer F; Lievense LA; Kaijen-Lambers ME; van Nimwegen M; Bezemer K; Hegmans JP; van Hall T; Hendriks RW; Aerts JG
    Cancer Immunol Res; 2017 Jul; 5(7):535-546. PubMed ID: 28536100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.
    Coniglio SJ; Eugenin E; Dobrenis K; Stanley ER; West BL; Symons MH; Segall JE
    Mol Med; 2012 May; 18(1):519-27. PubMed ID: 22294205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.
    Webb MW; Sun J; Sheard MA; Liu WY; Wu HW; Jackson JR; Malvar J; Sposto R; Daniel D; Seeger RC
    Int J Cancer; 2018 Sep; 143(6):1483-1493. PubMed ID: 29665011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
    Peranzoni E; Lemoine J; Vimeux L; Feuillet V; Barrin S; Kantari-Mimoun C; Bercovici N; Guérin M; Biton J; Ouakrim H; Régnier F; Lupo A; Alifano M; Damotte D; Donnadieu E
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4041-E4050. PubMed ID: 29632196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.